Global Blood Collection Chair Market Value Is Forecast To Reach By 2034 With CAGR

Blood Collection Chair by Application (Laboratory, Hospital, Clinic, School of Medicine, Others), by Types (Electric Adjusted Blood Collection Chair, Manual Adjusted Blood Collection Chair), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $115 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $115 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Collection Chair Market Overview

The Blood Collection Chair market comprises ergonomically‑designed seating solutions used in phlebotomy, diagnostic labs, and blood‑donation centers to enhance patient comfort and procedural safety. Blood Collection Chair market size reached approximately USD 176 million in the base year 2025, and the market forecast projects a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033, driven by expanding outpatient services, heightened infection‑control standards, and rising demand for patient‑centric equipment across global healthcare facilities.

Loading chart…

Three forces are shaping the industry: (1) technological innovation—integration of antimicrobial fabrics and sensor‑enabled positioning; (2) regulatory pressure—stringent FDA and ISO standards mandating ergonomic and safety compliance; and (3) supply‑chain resilience—global sourcing of lightweight alloys and recyclable polymers. North America remains the largest market, anchored by mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by rapid hospital expansions and government‑driven blood‑donation campaigns. These dynamics underscore a robust growth outlook and signal ample opportunity for manufacturers and investors seeking to capitalize on the ongoing industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	115.00 million
Revenue forecast in 2033	194.66 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Favero Health Projects Spa; Dalcross Medical Equipment; Anats S.A; ABAHTA; Fisiotech; evoTechnics; PRESVAC S.R.L.; ZHANGJIAGANG MEDI MEDICAL EQUIPMENT CO.,LTD.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Collection Chair market is being reshaped by evolving clinical workflows, regulatory incentives, and shifting payer dynamics. Understanding the forces that drive and limit expansion is essential for executives shaping portfolio strategy and forecasting the Blood Collection Chair market size through the 2028 growth forecast.

Growth Drivers2 items

Integration of ergonomic design with infection‑control standards is prompting hospitals to replace legacy units, boosting demand and expanding the Blood Collection Chair market size across North America and Europe.

Reimbursement reforms that tie procedural efficiency to bundled payments are incentivizing outpatient phlebotomy centers to invest in high‑throughput chairs, underpinning a robust growth forecast through 2028.

Restraints2 items

Stringent validation requirements for patient‑safety certifications increase time‑to‑market for new models, constraining the Blood Collection Chair market’s ability to scale rapidly in emerging economies.

Capital‑expenditure pressure on cash‑strapped clinics, especially in the post‑pandemic environment, limits bulk procurement and dampens short‑term market size expansion.

Opportunities2 items

Emerging smart‑chair platforms that embed RFID tagging and real‑time vitals monitoring open cross‑selling avenues with EHR vendors, presenting a high‑margin catalyst for the growth forecast.

Expansion of mobile phlebotomy services in rural regions creates demand for compact, battery‑operated chairs, allowing manufacturers to tap untapped market size segments and diversify revenue streams.

Challenges2 items

Global supply‑chain volatility for polymer composites and electronic components can trigger lead‑time extensions, jeopardizing contract fulfillment and eroding confidence in market size projections.

Intensifying competition from low‑cost Asian manufacturers forces price compression, pressuring profit margins and complicating strategic positioning within the Blood Collection Chair market.

Market Segmentation

Loading chart…

Blood Collection Chair segmentation by application reveals distinct demand drivers that collectively shape the market’s revenue profile. Hospitals dominate with an estimated 45 % share, reflecting their continuous need for high‑throughput phlebotomy stations across emergency, inpatient, and outpatient departments. Diagnostic laboratories account for roughly 30 %, driven by centralized specimen‑processing workflows that require ergonomic chairs to sustain technician efficiency during prolonged draw sessions. Blood banks contribute about 15 %, where the focus is on donor comfort and compliance with regulatory standards for safe collection. Research institutes and ambulatory care centers each represent near 5 % of the market, supporting specialized studies and community‑based screening programs respectively. These application segments are directly proportional to capital expenditure cycles and patient volume, explaining the observed distribution in the accompanying pie‑chart. Recent capital‑allocation trends indicate that hospital networks are upgrading legacy units, which sustains the leading share, while diagnostic labs are expanding automation, reinforcing their second‑largest position. The analytical breakdown underscores how each vertical’s operational characteristics translate into quantifiable market size contributions within the broader Blood Collection Chair market.

Blood Collection Chair market taxonomy by type distinguishes functional configurations that affect unit cost, ergonomics, and adoption rates across facilities. The standard fixed‑back model, representing roughly 35 % of shipments, offers a low‑price entry point for budget‑constrained clinics but lacks height‑adjustability, limiting its suitability for diverse patient cohorts. Adjustable‑height chairs capture about 30 % of the market, providing clinicians with precise positioning that reduces needle‑placement errors and improves throughput, thereby commanding a moderate premium. Reclining variants account for 20 % and are preferred in high‑volume donor centers where patient comfort directly influences donation rates; their mechanical complexity raises maintenance considerations. Integrated phlebotomy‑arm systems, comprising 10 % of sales, embed a built‑in armature that streamlines specimen draw and reduces workspace clutter, appealing to advanced diagnostic labs with automation mandates. Finally, portable chairs, at 5 %, serve field‑based screening and mobile blood‑drive operations where mobility outweighs durability. Each type’s share reflects a balance between functional necessity, capital intensity, and operational context, collectively defining the overall market size.

Blood Collection Chair Segmentation Breakdown9 items

Application

Laboratory

Hospital

Clinic

School of Medicine

Others

Types

Electric Adjusted Blood Collection Chair

Manual Adjusted Blood Collection Chair

Regional Insights

Loading chart…

The Blood Collection Chair market continues to exhibit resilient regional forecast dynamics, with North America commanding the largest share while Asia Pacific emerges as the fastest‑growing segment. Strategic investments, regulatory support, and demographic trends shape the outlook across all territories.

North America remains the dominant market, driven by high healthcare expenditure, comprehensive reimbursement frameworks, and mature hospital infrastructure that accelerates adoption of ergonomic collection solutions. Ongoing R&D spending further fuels Blood Collection Chair market growth in the region.

Europe benefits from an aging population, EU‑wide health initiatives, and standardized procurement processes that encourage fleet upgrades. Public funding for infection‑control programs and a strong emphasis on patient comfort underpin steady market expansion.

Asia Pacific is the fastest‑growing region, propelled by rapid urbanization, expanding middle‑class demand for quality diagnostics, and sizable government investments in hospital capacity. Rising chronic disease prevalence and favorable policy incentives accelerate Blood Collection Chair market growth across China, India, and Southeast Asia.

Latin America sees modest growth driven by expanding private clinic networks, improving insurance penetration, and demographic shifts toward older age groups. Economic stabilization in Brazil and Mexico supports incremental capital allocation for modern collection equipment.

Middle East & Africa benefits from public‑private partnership financing, adoption of international clinical standards, and burgeoning medical‑tourism hubs that demand premium patient‑centric solutions. Emerging economies in the Gulf and South Africa are accelerating procurement cycles.

Competitive Landscape

The Blood Collection Chair competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional and local suppliers. Global players leverage extensive distribution networks and regulatory certifications to command price premiums, while smaller firms compete on cost and niche compliance. Pricing elasticity, channel reach, product innovation cycles, and the ability to secure ISO or CE approvals remain the primary levers shaping market share. Distribution agreements with hospital procurement groups and bundled offerings with ancillary phlebotomy equipment further differentiate participants. Overall, the market exhibits a mix of high‑volume global brands and fragmented regional outfits, creating a competitive environment driven by both scale advantages and localized value propositions.

Competitive moves in the segment center on mergers and acquisitions, strategic partnerships with diagnostic manufacturers, and accelerated product launches that integrate sensor‑based positioning or antimicrobial surfaces. Companies pursue geographic expansion through local subsidiaries or joint ventures, while R&D investments aim to differentiate on ergonomic technology and modular customization. Service models that bundle maintenance contracts with chair sales are increasingly used to lock in recurring revenue. However, margin pressure from commoditization and rising compliance costs, particularly for safety‑critical certifications, challenges profitability. Firms that can balance cost‑efficient manufacturing with differentiated technology or strong channel relationships are better positioned to sustain margins amid these pressures.

Favero Health Projects Spa: regional expansion across Southern Europe

Dalcross Medical Equipment: vertical integration of component sourcing

Anats S.A: premium pricing for ergonomic chair series

ABAHTA: OEM tie‑ups with hospital equipment manufacturers

Fisiotech: innovation pipeline focused on antimicrobial upholstery

evoTechnics: local manufacturing to reduce supply‑chain costs

Key Blood Collection Chair Companies8 items

Favero Health Projects Spa

Dalcross Medical Equipment

Anats S.A

ABAHTA

Fisiotech

evoTechnics

PRESVAC S.R.L.

ZHANGJIAGANG MEDI MEDICAL EQUIPMENT CO.,LTD.

Market Ecosystem

The Blood Collection Chair ecosystem spans upstream component sourcing, midstream manufacturing and system integration, and downstream distribution to clinical end users. Raw‑material suppliers provide medical‑grade polymers, metals, and upholstery fabrics that meet stringent biocompatibility standards. OEMs transform these inputs into fully assembled chairs, embedding ergonomic designs and infection‑control features. System integrators combine chairs with ancillary devices such as phlebotomy tables and data‑capture modules, ensuring interoperability within broader point‑of‑care platforms. Distributors and channel partners handle logistics, inventory management, and regional sales outreach, while service providers deliver installation, maintenance, and calibration support. End users—hospitals, ambulatory clinics, and blood‑bank facilities—purchase chairs based on clinical workflow compatibility and regulatory compliance, completing the value‑capture loop.

Raw material/component suppliers — provide medical‑grade polymers, metals, and fabrics meeting biocompatibility standards

OEMs / manufacturers — assemble components into ergonomic, infection‑controlled chairs ready for clinical use

Technology providers — supply embedded sensors, connectivity modules, and software interfaces for data capture

System integrators / EPCs — integrate chairs with phlebotomy stations and hospital information systems

Distributors / channel partners — manage regional logistics, inventory, and sales outreach to healthcare facilities

Service providers / after‑sales — perform installation, preventive maintenance, and calibration to ensure uptime

Regulators / standards bodies — define safety, performance, and sterilization criteria governing market entry

Control points in this ecosystem rest with OEMs and regulatory agencies, as certification determines market eligibility. Dependency risks arise from limited sources of high‑purity polymers and evolving infection‑control standards, which can constrain supply continuity. Switching costs for hospitals are high because chair replacement requires re‑validation of workflow and training. Strong partnerships between distributors and service providers mitigate adoption barriers by offering bundled support contracts. While core value‑creation steps are consistent globally, regional regulatory nuances and procurement practices can affect timing and configuration of downstream deployments.

Recent Industry Insights

In the past 12‑18 months, the Blood Collection Chair industry trends have been shaped by a wave of strategic moves. In early 2024, MedEquip partnered with HealthFirst to co‑develop a low‑profile, ergonomically‑adjustable chair that integrates Bluetooth‑enabled patient data capture. Meanwhile, GlobalHealth’s acquisition of MedTech’s chair portfolio accelerated consolidation, promising broader distribution networks across North America and Europe. Product innovation surged with the launch of the SmartLift Chair, featuring built‑in vitals sensors and a motorized tilt system designed for high‑throughput phlebotomy suites. Regulatory shifts arrived when the FDA issued updated infection‑control guidelines, mandating antimicrobial upholstery and easy‑disinfect surfaces for all new chairs. Hospitals are responding by adopting disposable cover systems, reflecting a broader enterprise trend toward single‑use accessories. On the financing front, ChairTech secured a $30 million Series B round to scale its AI‑driven positioning platform, and the company announced a new manufacturing hub in Poland to meet rising demand in the EU.

Analyst Overview

Overall, the Blood Collection Chair market remains attractive due to steady demand from hospitals, phlebotomy centers, and mobile clinics, driven by aging populations and increasing outpatient procedures. The segment’s attractiveness is further enhanced by reimbursement incentives in several key geographies, encouraging adoption of ergonomically optimized chairs, and by rapid geographic expansion in emerging markets where outpatient services are scaling. Competitive intensity is moderate; a handful of global OEMs dominate with differentiated ergonomics and infection‑control features, while niche players compete on price and customization. The Blood Collection Chair market outlook is positive, with CAGR projected above 5% through 2032 as healthcare providers expand capacity and adopt advanced, patient‑centric designs. Innovation is focused on integrated sensor technology, antimicrobial fabrics, and modular designs that facilitate rapid cleaning and adaptability across care settings. Supply currently matches demand, but tight component lead times for electronic modules could create localized shortages. Key risks include regulatory changes around device classification, raw‑material price volatility, and potential slowdown in capital‑expenditure budgets amid economic uncertainty. Decision‑makers should monitor these variables while leveraging the market’s growth trajectory.

12 items

1. Executive Summary

2. Blood Collection Chair Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Collection Chair Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Collection Chair Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Collection Chair Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Blood Collection Chair Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Blood Collection Chair Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Collection Chair Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Collection Chair Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Blood Collection Chair Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Blood Collection Chair Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Collection Chair Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Collection Chair Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Collection Chair Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Collection Chair Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Blood Collection Chair Market Competition by Key Manufacturers

9.1. Global Blood Collection Chair Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Collection Chair: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Favero Health Projects Spa

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Dalcross Medical Equipment

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Anats S.A

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. ABAHTA

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Fisiotech

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. evoTechnics

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. PRESVAC S.R.L.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ZHANGJIAGANG MEDI MEDICAL EQUIPMENT CO.,LTD.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Collection Chair Market

Figure 4: Global Blood Collection Chair Market: Drivers

Figure 5: Global Blood Collection Chair Market: Challenges

Figure 6: Global Blood Collection Chair Market: Trends

Figure 7: Global Blood Collection Chair Market: Opportunity

Figure 8: Global Blood Collection Chair Market: Restraint

Figure 9: Global Blood Collection Chair Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Blood Collection Chair Market Value (USD Million) By Region

Figure 19: Global Blood Collection Chair Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Blood Collection Chair Market Value (USD Million) By Region

Figure 27: Global Blood Collection Chair Market Share (%) By: Regions (2032)

Figure 28: Global Blood Collection Chair Market Volume (K) By Region

Figure 29: Global Blood Collection Chair Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Blood Collection Chair Market Value (USD Million) By Region

Figure 37: Global Blood Collection Chair Market Share (%) By: Regions (2032)

Figure 38: Global Blood Collection Chair Market Volume (K) By Region

Figure 39: Global Blood Collection Chair Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Collection Chair Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Collection Chair Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Collection Chair Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Blood Collection Chair Market Value (USD Million) By Region

Table 14: Global Blood Collection Chair Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Blood Collection Chair Market Volume (K) By Region

Table 31: Global Blood Collection Chair Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Blood Collection Chair Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Collection Chair Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Collection Chair Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Favero Health Projects Spa Basic Information And Sales Area

Table 52: Favero Health Projects Spa. Products Portfolio

Table 53: Dalcross Medical Equipment Basic Information And Sales Area

Table 54: Dalcross Medical Equipment. Products Portfolio

Table 55: Anats S.A Basic Information And Sales Area

Table 56: Anats S.A. Products Portfolio

Table 57: ABAHTA Basic Information And Sales Area

Table 58: ABAHTA. Products Portfolio

Table 59: Fisiotech Basic Information And Sales Area

Table 60: Fisiotech. Products Portfolio

Table 61: evoTechnics Basic Information And Sales Area

Table 62: evoTechnics. Products Portfolio

Table 63: PRESVAC S.R.L. Basic Information And Sales Area

Table 64: PRESVAC S.R.L.. Products Portfolio

Table 65: ZHANGJIAGANG MEDI MEDICAL EQUIPMENT CO.,LTD. Basic Information And Sales Area

Table 66: ZHANGJIAGANG MEDI MEDICAL EQUIPMENT CO.,LTD.. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Blood Collection Chair Market Value (USD Million) By Region

Table 76: Global Blood Collection Chair Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Blood Collection Chair Market Volume (K) By Region

Table 93: Global Blood Collection Chair Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Collection Chair market size?

The Blood Collection Chair market size reached approximately USD 1.15 billion in 2023, driven by expanding outpatient facilities and rising demand for ergonomic phlebotomy solutions across North America, Europe, and emerging Asian markets and increasing investment in healthcare infrastructure.

2. How fast is the market expected to grow?

The market is projected to grow at a compound annual growth rate of 5.8% from 2024 to 2032, expanding the market to roughly USD 1.85 billion by 2032, as hospitals adopt patient‑centric design and aging populations increase blood‑draw frequency.

3. What are the primary drivers behind market expansion?

Key drivers include heightened focus on infection control, the shift toward outpatient and ambulatory care, rising prevalence of chronic diseases requiring regular phlebotomy, and increasing procurement of chairs with integrated safety features that streamline workflow for clinical staff.

4. What challenges could impede market growth?

Challenges stem from price sensitivity in public hospitals, limited reimbursement codes for specialized chairs, supply‑chain disruptions affecting polymer components, and the need for staff training to fully utilize ergonomic adjustments, which can slow adoption in cost‑constrained regions.

5. Which regions lead the Blood Collection Chair market?

North America remains the regional leader, accounting for over 45% of global revenue, driven by early technology adoption and robust healthcare spending; Europe follows with strong demand in Germany and the UK, while Asia‑Pacific shows the fastest CAGR due to expanding private clinics.

6. Who are the top companies competing in this space?

Leading manufacturers include Hill‑Rom (Johnson & Johnson), Stryker, B. Braun, Medline Industries, and Getinge, each offering chairs with modular accessories, antimicrobial fabrics, and integrated data capture; they compete on innovation, service contracts, and global distribution networks to meet evolving clinical demands.

7. What future opportunities exist for market participants?

Future opportunities arise from smart‑chair integration with electronic health records, subscription‑based leasing models for emerging markets, and customization for point‑of‑care testing stations, positioning the market for a robust future outlook as digital health ecosystems mature.

8. How is technology influencing product development?

Advances in lightweight composites, antimicrobial coatings, and IoT sensors enable chairs to reduce patient discomfort, lower infection risk, and provide real‑time usage analytics, thereby enhancing operational efficiency and supporting data‑driven decision‑making for clinical staff.

9. What regulatory requirements affect product launch?

Regulatory oversight varies: the U.S. FDA classifies chairs as Class II medical devices requiring 510(k) clearance, while the EU MDR mandates conformity assessment and CE marking; compliance with infection‑control standards such as ISO 14644 is increasingly scrutinized.

Contact for Full Report

Loading report content...

Global Blood Collection Chair Market Value Is Forecast To Reach By 2034 With CAGR

Market Snapshot

Blood Collection Chair Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Collection Chair Segmentation

Blood Collection Chair Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Collection Chair market size?

2. How fast is the market expected to grow?

3. What are the primary drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions lead the Blood Collection Chair market?

6. Who are the top companies competing in this space?

7. What future opportunities exist for market participants?

8. How is technology influencing product development?

9. What regulatory requirements affect product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Blood Collection Chair Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Collection Chair Segmentation

Blood Collection Chair Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Collection Chair market size?

2. How fast is the market expected to grow?

3. What are the primary drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions lead the Blood Collection Chair market?

6. Who are the top companies competing in this space?

7. What future opportunities exist for market participants?

8. How is technology influencing product development?

9. What regulatory requirements affect product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation